Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Korey Jaben"'
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 19, Iss , Pp 100607- (2020)
Purpose: To describe a case of primary lacrimal sac adenocarcinoma treated primarily with androgen deprivation therapy (ADT) with good clinic response. Observations: An 82-year-old male presented with a painless right orbital mass. Pathology followin
Externí odkaz:
https://doaj.org/article/34f9a3605bcd438d8ad866406101e6d2
Autor:
Christopher A. Barker, Ivana K. Kim, M. Kurli, Jill R. Wells, Baker Hubbard, Codrin Iacob, Jasmine H. Francis, Jedd D. Wolchok, Hans E. Grossniklaus, Korey Jaben, Hakan Demirci, Michael A. Postow, Chris S. Bergstrom, Duncan E. Berry, Michael Engelbert, David H. Abramson
Publikováno v:
Ophthalmology. 127:240-248
Purpose Cutaneous melanoma metastatic to the vitreous is very rare. This study investigated the clinical findings, treatment, and outcome of patients with metastatic cutaneous melanoma to the vitreous. Most patients received checkpoint inhibition for
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 19, Iss, Pp 100799-(2020)
American Journal of Ophthalmology Case Reports
American Journal of Ophthalmology Case Reports
Purpose To report asymptomatic progressive fundus depigmentation and choroidal thinning in the absence of intraocular inflammation in a patient treated with checkpoint inhibitors. Observations A 69-year-old woman with metastatic cutaneous melanoma, t
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 19, Iss, Pp 100607-(2020)
American Journal of Ophthalmology Case Reports
American Journal of Ophthalmology Case Reports
Purpose To describe a case of primary lacrimal sac adenocarcinoma treated primarily with androgen deprivation therapy (ADT) with good clinic response. Observations An 82-year-old male presented with a painless right orbital mass. Pathology following
Autor:
Jasmine H. Francis, Korey Jaben, Bianca D. Santomasso, Julia Canestraro, David H. Abramson, Meghan Berkenstock, Mary E. Aronow
Publikováno v:
Ophthalmology. 127(11)
Autor:
Meghan Berkenstock, Mary E. Aronow, Julia Canestraro, Jasmine H. Francis, David H. Abramson, Korey Jaben, Bianca Santomasso, Paul B. Chapman
Publikováno v:
Ophthalmology
The three classes of immune checkpoint inhibitors can be associated with optic neuritis, which typically presents with bilateral, painless visual decline. Visual function stabilized with drug cessation and systemic steroids.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6c685740396349c43e2e0bda12b6ca
https://europepmc.org/articles/PMC8488949/
https://europepmc.org/articles/PMC8488949/
Publikováno v:
Ocul Oncol Pathol
Background: Central retinal vein occlusion (CRVO) is a visually threatening event that has rarely been observed in patients taking MEK1/2 inhibitors and that may necessitate permanent discontinuation of a potentially efficacious therapy. We investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f832f8da1c77168404a2b74442258b3b
https://europepmc.org/articles/PMC7250324/
https://europepmc.org/articles/PMC7250324/
Autor:
Jasmine H, Francis, Duncan, Berry, David H, Abramson, Christopher A, Barker, Chris, Bergstrom, Hakan, Demirci, Michael, Engelbert, Hans, Grossniklaus, Baker, Hubbard, Codrin E, Iacob, Korey, Jaben, Madhavi, Kurli, Michael A, Postow, Jedd D, Wolchok, Ivana K, Kim, Jill R, Wells
Publikováno v:
Ophthalmology
PURPOSE: Cutaneous melanoma metastatic to the vitreous is very rare. This study investigates the clinical findings, treatment and outcome of patients with metastatic cutaneous melanoma to the vitreous. The majority of patients received checkpoint inh
Publikováno v:
Neuroophthalmology
Pembrolizumab is a checkpoint inhibitor targeting the programmed cell death 1 receptor of lymphocytes and is used in the treatment of solid tumours including melanoma. The authors report a 64-year-old man treated with pembrolizumab for stage IV cutan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a76b826c3de325395595817a7a784650
https://europepmc.org/articles/PMC7202430/
https://europepmc.org/articles/PMC7202430/
Autor:
Alexis Furze, Deanna Kralick, Anand Vakharia, Korey Jaben, Reid Graves, Eelam Adil, Adrien A. Eshraghi, Thomas J. Balkany, Thomas R. Van de water
Publikováno v:
Acta oto-laryngologica. 128(2)
Dexamethasone and methylprednisolone do not inhibit neuritic outgrowth while inhibiting fibroblastic outgrowth from spiral ganglion micro-explants.To demonstrate reduced fibroblastic outgrowth while maintaining neurite outgrowth for several corticost